Close Menu

NEW YORK – Responding to a severe shortage of tests for the novel coronavirus in the state of New York, the US Food and Drug Administration on Thursday gave the New York State Department of Health permission to authorize New York laboratories to begin patient testing.

In a statement issued on Friday, the agency said it is "not objecting" to the NYSDOH's approach, under which labs need to provide validation data to the health department within 15 days of starting testing instead of having to pursue an Emergency Use Authorization with the FDA.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A survey by Nature finds that most researchers want scientific meetings to continue virtually or with a virtual component, even after the pandemic ends.

Bloomberg reports that the B.1.351 SARS-CoV-2 viral variant could prompt the formulation of better vaccines.

Certain blood proteins may be able to distinguish COVID-19 patients who will become critically ill from those who will not, the Atlanta Journal-Constitution reports.

In Genome Biology this week: algorithm to assess regulatory features, approach to integrate multiple single-cell RNA-seq datasets, and more.